Endocrinology

Top Story

High drug prices result of government protection in US

August 25, 2016

The high cost of prescription drugs in the United States is the result of drug manufacturers being granted government-protected monopolies, according to data published in JAMA Internal Medicine.

“The increasing cost of prescription drugs in the United States has become a source of growing concern for patients, prescribers, payers and policy makers,” Aaron S. Kesselheim, MD, JD, MPH, of the department of medicine at Brigham and Women’s Hospital and Harvard Medical School, and colleagues wrote. “In addition to their contribution to health care spending, increasing drug costs have important clinical implications. It is therefore important to understand what factors have contributed to recent medication price increases to lay the foundation for considering options to ensure that prescription drug expenditures are commensurate with their value, affordable within health budgets, and equitable for all parties involved in these complex transactions.”

In the Journals Plus

GH therapy continuation in Prader-Willi syndrome beneficial

August 25, 2016
Continuation of growth hormone therapy in young adults with Prader-Willi syndrome who have reached adult height can help to reduce fat mass and increase lean body mass…
In the Journals Plus

HbA1c more sensitive than OGTT for identifying prediabetes

August 25, 2016
HbA1c and oral glucose tolerance tests used to identify prediabetes yielded conflicting results in both Hispanic and non-Hispanic white populations in New Mexico, study…
In the Journals Plus

New European blood pressure targets for diabetes may put patients at risk

August 24, 2016
Recently raised systolic blood pressure targets for people with diabetes may put them at elevated risk for stroke and myocardial infarction, study data show. In…
In the Journals Plus

Eight additional cancer types associated with excess body fatness

August 24, 2016
The WHO’s International Agency for Research on Cancer working group identified an additional eight types of cancer associated with excess body fatness, including…
More News Headlines »
CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Video
Meeting News Coverage

VIDEO: Diabetes educators can help people with diabetes overcome barriers to exercise

August 16, 2016
More »
Featured
ADA 2016

ADA 2016

CME CNE CPE

The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Current Issues
View the Current Issues